Evidence map›Paper›PMID 27531718›Full record

ArticleGenome research2016

Indels, structural variation, and recombination drive genomic diversity in Plasmodium falciparum.

Alistair Miles, Zamin Iqbal, Paul Vauterin, Richard Pearson, Susana Campino, Michel Theron, Kelda Gould, Daniel Mead, Eleanor Drury, John O'Brien and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 156 papers.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

156 citing papers in PubMed, 266 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Unpacking boxes: identification of novel inhibitors of malaria parasite invasion.International journal for parasitology. Drugs and drug resistance · 2026
    Article
  5. Single-cell analysis ofbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Towards an evolutionary baseline model ofbioRxiv : the preprint server for biology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Parasitology · 2025
    Article

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 4 countries.

Alistair MilesMRC Centre for Genomics and Global Health, University of Oxford, Oxford OX3 7BN, United Kingdom; Malaria Programme, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom;
Zamin IqbalWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom;
Paul VauterinMRC Centre for Genomics and Global Health, University of Oxford, Oxford OX3 7BN, United Kingdom;
Richard PearsonMRC Centre for Genomics and Global Health, University of Oxford, Oxford OX3 7BN, United Kingdom; Malaria Programme, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom;
Susana CampinoMalaria Programme, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom;
Michel TheronMalaria Programme, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom;
Kelda GouldMalaria Programme, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom;
Daniel MeadMalaria Programme, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom;
Eleanor DruryMalaria Programme, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom;
John O'BrienBowdoin College, Brunswick, Maine 04011, USA;
Valentin Ruano RubioBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA;
Bronwyn MacInnisBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA;
Jonathan MwangiDepartment of Biochemistry, Medical School, Mount Kenya University, 01000 Thika, Kenya; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom;
Upeka SamarakoonEck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556, USA;
Lisa Ranford-CartwrightInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom;
Michael FerdigEck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556, USA;
Karen HaytonLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland 20892-9806, USA;
Xin-Zhuan SuLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland 20892-9806, USA;
Thomas WellemsLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland 20892-9806, USA;
Julian RaynerMalaria Programme, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom;
Gil McVeanWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom; Department of Statistics, University of Oxford, Oxford OX1 3LB, United Kingdom.
Dominic KwiatkowskiMRC Centre for Genomics and Global Health, University of Oxford, Oxford OX3 7BN, United Kingdom; Malaria Programme, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom;
Wellcome Sanger Institute · GBNational Institutes of Health · USBroad Institute · USCentre for Human Genetics · GBUniversity of Notre Dame · USBowdoin College · USInstitute of Infection and Immunity · CAMount Kenya University · KEUniversity of Oxford · GB

Funding

Malaria Drug Resistance and Disease VirulenceZIAAI000483 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI WELLEMS, THOMAS E · 2009 to 2025
$24.5M
Malaria Parasite Sexual Development, Drug Resistance, and EvolutionZIAAI000892 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SU, XINZHUAN · 2009 to 2025
$23.3M
Medical Research Council MR/M006212/1Wellcome Trust 090770/Z/09/ZWellcome Trust 091791Wellcome Trust 098051
6 · The paper itself

Abstract

The malaria parasite Plasmodium falciparum has a great capacity for evolutionary adaptation to evade host immunity and develop drug resistance. Current understanding of parasite evolution is impeded by the fact that a large fraction of the genome is either highly repetitive or highly variable and thus difficult to analyze using short-read sequencing technologies. Here, we describe a resource of deep sequencing data on parents and progeny from genetic crosses, which has enabled us to perform the first genome-wide, integrated analysis of SNP, indel and complex polymorphisms, using Mendelian error rates as an indicator of genotypic accuracy. These data reveal that indels are exceptionally abundant, being more common than SNPs and thus the dominant mode of polymorphism within the core genome. We use the high density of SNP and indel markers to analyze patterns of meiotic recombination, confirming a high rate of crossover events and providing the first estimates for the rate of non-crossover events and the length of conversion tracts. We observe several instances of meiotic recombination within copy number variants associated with drug resistance, demonstrating a mechanism whereby fitness costs associated with resistance mutations could be compensated and greater phenotypic plasticity could be acquired.

Indexed as

Genetic VariationChromosome MappingDNA Copy Number VariationsDrug ResistanceGenome, ProtozoanHigh-Throughput Nucleotide SequencingHumansINDEL MutationMalaria, FalciparumMeiosisPlasmodium falciparumPolymorphism, Single NucleotideRecombination, Genetic

Identifiers

PMID27531718
PMCPMC5052046
OpenAlexW2514285416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.